Skip to content

EJHP Highlights: Telaprevir and Boceprevir for treatment of Hepatitis C

Ahead of the WHO’s World Hepatitis Day, EAHP’s EU Monitor highlights a recent EJHP article by Mark Nolan on the use of antiviral protease inhibitors Telaprevir and Boceprevir for the treatment of Hepatitis C.
The article discus

ses some of the special points about both medicines, including patient counselling around such issues as adverse reactions, drug interactions and medication storage.

Full article available here

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.